Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Voyager Therapeutics (VYGR) Gains from Sales and Divestitures (2016 - 2026)

Voyager Therapeutics' Gains from Sales and Divestitures history spans 11 years, with the latest figure at $691107.0 for Q4 2025.

  • On a quarterly basis, Gains from Sales and Divestitures rose 34.12% to $691107.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $691107.0, a 34.12% increase, with the full-year FY2025 number at $691107.0, up 34.12% from a year prior.
  • Gains from Sales and Divestitures hit $691107.0 in Q4 2025 for Voyager Therapeutics, up from $568331.0 in the prior quarter.
  • Over the last five years, Gains from Sales and Divestitures for VYGR hit a ceiling of $691107.0 in Q4 2025 and a floor of $184217.0 in Q1 2021.
  • Historically, Gains from Sales and Divestitures has averaged $416912.0 across 5 years, with a median of $421680.5 in 2022.
  • Biggest five-year swings in Gains from Sales and Divestitures: skyrocketed 129.71% in 2021 and later decreased 13.33% in 2024.
  • Tracing VYGR's Gains from Sales and Divestitures over 5 years: stood at $326943.0 in 2021, then skyrocketed by 33.54% to $436611.0 in 2022, then increased by 21.75% to $531560.0 in 2023, then fell by 3.06% to $515303.0 in 2024, then skyrocketed by 34.12% to $691107.0 in 2025.
  • Business Quant data shows Gains from Sales and Divestitures for VYGR at $691107.0 in Q4 2025, $568331.0 in Q3 2025, and $550084.0 in Q2 2025.